Me-lex is a sequence-specific
alkylating agent synthesized to preferentially (>90%) generate
N3-methyladenine (3-mA) in the minor groove of double-strand
DNA, in A-T rich regions. In this paper we investigated the effect of XRCC1 deficiency in the processing of 3-mA adducts generated by
Me-lex, through the molecular analysis of the
Hprt mutations and the evaluation of cytogenetic end points such as sister chromatid exchanges (SCEs), micronuclei (MN) and nucleus fragmentation. EM-C11 cells, deficient in XRCC1 activity, showed a 2.5-fold higher sensitivity to the toxicity of
Me-lex compared to the DNA repair proficient parental CHO-9 cells, but were not hyper mutable. The spontaneous mutation spectrum at the
Hprt locus generated in EM-C11 cells revealed a high percentage of genomic deletions. After
Me-lex treatment, the percentage of genomic deletions did not increase, but a class of mutations which appeared to target regulatory regions of the gene significantly increased (p=0.0277), suggesting that non-coding
Hprt genomic sequences represent a strong target for the rare mutations induced by
Me-lex. The number of SCEs per chromosome increased 3-fold above background in 50mucapital EM, Cyrillic
Me-lex treated CHO-9 cells, while at higher
Me-lex concentrations a sharp increase in the percentage of MN and fragmented nuclei was observed. In EM-C11 cells the background level of SCEs (0.939+/-0.182) was approximately 10-fold higher than in CHO-9 (0.129+/-0.027) and higher levels of multinucleated cells and MN were also found. In EM-C11, even low doses of
Me-lex (25microM) led to a significant increase in genomic damage. These results indicate that XRCC1 deficiency can lead to
genomic instability even in the absence of an exogenous genotoxic insult and low levels of
Me-lex-induced lesions, i.e., 3-mA and/or a BER intermediate, can exacerbate this instability.